top of page
DRIVING BETTER PATIENT ACCESS TO CANCER PATIENTS WITH THERANOSTICS
Oncothera is focused on proving patients equitable access to the latest medicine within theranostics
About Oncothera
New treatments are urgently needed for cancer patients. Oncothera's vision is to enable all stakeholders for theranostic treatment to work together to provide accessible treatment for patients.
We have pro-actively consulted widely with different stakeholders since 2024 and with our medical steering committee finalised the following goals.
Advocacy Goals
Collaborate across the value chain
​Create clear market access pathway aligned to global markets including GMP manufacture
Increase profile of theranostics to government to secure long term investment in sector
Atttract, build, train and retain world class talent
Strategy into Action
Oncothera White Paper
Medical Steering Committee
Theranostic resource development
Awareness raising
Patient treatment accessibility
bottom of page